Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Chan

Showing results (321-330 of 449) with videos related to

Pageof 45
Sort By:
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 16, 2024
Exploring the relationship between neurologists and older persons with multiple sclerosis through the lens of social support theoryMina Stanikić, Felix Gille, Jonas Schlomberg, et al.
ACS Applied Materials & Interfaces|August 18, 2015
Solvent-Free Click-Mechanochemistry for the Preparation of Cancer Cell Targeting Graphene OxideNoelia Rubio, Kuo-Ching Mei, Rebecca Klippstein, et al.
Cell Death Discovery|August 9, 2023
Nogo-A antibody delivery through the olfactory mucosa mitigates experimental autoimmune encephalomyelitis in the mouse CNSVincent Pernet, Sandrine Joly, Sebastian Spiegel, et al.
Frontiers in Immunology|November 3, 2022
Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year inMaura Pugliatti, Hans-Peter Hartung, Celia Oreja-Guevara, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 14, 2022
Early Reduction of MRI Activity During 6 Months of Treatment With Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis: MAGNIFY-MSNicola de Stefano, Frederik Barkhof, Xavier Montalban, et al.
JMIR Mhealth and Uhealth|January 23, 2026
Acceptability of Telehealth as the Default Modality for Multiple Sclerosis Care in Switzerland: Cross-Sectional StudySintieh Nchinda Ngek Ekongefeyin, Paola Daniore, Vasileios Nittas, et al.
Therapeutic Advances in Neurological Disorders|October 22, 2019
Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease courseGreta Zoehner, Andrei Miclea, Anke Salmen, et al.
JAMA Neurology|May 19, 2015
Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum DisorderMarius Ringelstein, Ilya Ayzenberg, Jens Harmel, et al.
Multiple Sclerosis and Related Disorders|December 12, 2018
Patterns of care for Multiple Sclerosis in a setting of universal care access: A cross-sectional studyLaura Barin, Marco Kaufmann, Anke Salmen, et al.
PLOS Digital Health|August 22, 2024
Feasibility characteristics of wrist-worn fitness trackers in health status monitoring for post-COVID patients in remote and rural areasMadeleine Wiebe, Marnie Mackay, Ragur Krishnan, et al.
Pageof 45

Showing results (321-330 of 449) with videos related to

Sort By:
Pageof 45
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 16, 2024
Exploring the relationship between neurologists and older persons with multiple sclerosis through the lens of social support theoryMina Stanikić, Felix Gille, Jonas Schlomberg, et al.
ACS Applied Materials & Interfaces|August 18, 2015
Solvent-Free Click-Mechanochemistry for the Preparation of Cancer Cell Targeting Graphene OxideNoelia Rubio, Kuo-Ching Mei, Rebecca Klippstein, et al.
Cell Death Discovery|August 9, 2023
Nogo-A antibody delivery through the olfactory mucosa mitigates experimental autoimmune encephalomyelitis in the mouse CNSVincent Pernet, Sandrine Joly, Sebastian Spiegel, et al.
Frontiers in Immunology|November 3, 2022
Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year inMaura Pugliatti, Hans-Peter Hartung, Celia Oreja-Guevara, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 14, 2022
Early Reduction of MRI Activity During 6 Months of Treatment With Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis: MAGNIFY-MSNicola de Stefano, Frederik Barkhof, Xavier Montalban, et al.
JMIR Mhealth and Uhealth|January 23, 2026
Acceptability of Telehealth as the Default Modality for Multiple Sclerosis Care in Switzerland: Cross-Sectional StudySintieh Nchinda Ngek Ekongefeyin, Paola Daniore, Vasileios Nittas, et al.
Therapeutic Advances in Neurological Disorders|October 22, 2019
Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease courseGreta Zoehner, Andrei Miclea, Anke Salmen, et al.
JAMA Neurology|May 19, 2015
Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum DisorderMarius Ringelstein, Ilya Ayzenberg, Jens Harmel, et al.
Multiple Sclerosis and Related Disorders|December 12, 2018
Patterns of care for Multiple Sclerosis in a setting of universal care access: A cross-sectional studyLaura Barin, Marco Kaufmann, Anke Salmen, et al.
PLOS Digital Health|August 22, 2024
Feasibility characteristics of wrist-worn fitness trackers in health status monitoring for post-COVID patients in remote and rural areasMadeleine Wiebe, Marnie Mackay, Ragur Krishnan, et al.
Pageof 45